Crewe Advisors’s Axcelis ACLS Stock Holding History

Crewe Advisors’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-27	Closed	-$3.01K	–	938
2024 Q1	$3.01K	Hold	27	–	–	﹤0.01%	815
2023 Q4	$3.5K	Buy	+27	New	+$3.72K	﹤0.01%	270
2023 Q3	–	Sell	-1	Closed	-$184	–	588
2023 Q2	$184	Buy	+1	New	+$144	﹤0.01%	730

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Crewe Advisors's ACLS Position: Q2 2024 in Review

Crewe Advisors sold out of Axcelis (ACLS) in Q2 2024, closing a stake of 27 shares — an estimated $3.01K sold.

Crewe Advisors first reported a position in ACLS in Q2 2023 and held it in 3 quarters. The position peaked at $3.5K in Q4 2023. 392 funds tracked by Wall St. Rank hold ACLS as of Q2 2024.

Crewe Advisors reported no remaining Axcelis position as of Q2 2024 after selling out during the quarter.
Crewe Advisors sold 27 Axcelis shares in Q2 2024, an estimated $3.01K.
Crewe Advisors first reported a position in Axcelis in Q2 2023 and held it in 3 quarters.
Crewe Advisors's Axcelis position peaked at $3.5K in Q4 2023.
392 funds tracked by Wall St. Rank held Axcelis as of Q2 2024.

Based on Crewe Advisors's 13F filing for Q2 2024, filed 29 Jul 2024.